Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF182 ZNF845 ZNF142 ZEB1 ZSCAN12 SALL2 ZNF484 ZNF341 ZNF41 GLI2 ZFP41 ZNF180 GLIS2 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ATF2 TET3 ZNF548 ZEB2 ZFP82 ZFP37 ZNF587B ZNF710	1.91e-18	1459	94	37	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF182 ZNF845 ZNF142 ZEB1 ZSCAN12 SALL2 ZNF484 ZNF341 ZNF41 GLI2 ZFP41 ZNF180 GLIS2 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF860 ZNF772 ZNF229 RREB1 ZNF496 ATF2 ZNF548 ZEB2 ZFP82 ZFP37 ZNF587B	2.71e-15	1412	94	33	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF182 ZNF845 ZEB1 ZSCAN12 SALL2 ZNF484 ZNF341 ZNF41 GLI2 GLIS2 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ATF2 TET3 ZNF548 ZEB2 ZFP82 ZNF710	3.26e-14	1244	94	30	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF182 ZNF845 ZEB1 ZSCAN12 SALL2 ZNF484 ZNF341 ZNF41 GLI2 GLIS2 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ATF2 TET3 ZNF548 ZEB2 ZFP82 ZNF710	5.73e-14	1271	94	30	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	ZNF845 SALL2 ZNF484 ZNF341 GLI2 GLIS2 ZNF814 PLAG1 ZNF721 ZNF229 RREB1 ATF2 ZEB2	2.45e-06	566	94	13	GO:0001216
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	ZNF845 SALL2 ZNF484 GLI2 GLIS2 ZNF814 PLAG1 ZNF721 ZNF229 RREB1 ATF2 ZEB2	1.24e-05	560	94	12	GO:0001228
GeneOntologyMolecularFunction	histone modifying activity	JARID2 RSBN1 USP51 NSD2 ASH1L HDAC10 ATF2	1.05e-04	229	94	7	GO:0140993
GeneOntologyMolecularFunction	histone H3K36 trimethyltransferase activity	NSD2 ASH1L	2.17e-04	5	94	2	GO:0140955
GeneOntologyMolecularFunction	protein serine kinase activity	NUAK1 NEK10 NEK8 NRK MINK1 IRAK4 MAP4K4 NUAK2	3.16e-04	363	94	8	GO:0106310
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	JARID2 NSD2 ASH1L	1.16e-03	44	94	3	GO:0140938
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	NUAK1 NEK10 NEK8 NRK MINK1 IRAK4 MAP4K4 NUAK2	1.21e-03	446	94	8	GO:0004674
GeneOntologyMolecularFunction	histone H3K36 methyltransferase activity	NSD2 ASH1L	1.65e-03	13	94	2	GO:0046975
GeneOntologyMolecularFunction	monoatomic cation:bicarbonate symporter activity	SLC4A7 SLC39A10	1.65e-03	13	94	2	GO:0140410
GeneOntologyBiologicalProcess	positive regulation of serine-type peptidase activity	SEMG1 SEMG2	6.02e-05	3	93	2	GO:1902573
GeneOntologyBiologicalProcess	positive regulation of serine-type endopeptidase activity	SEMG1 SEMG2	6.02e-05	3	93	2	GO:1900005
GeneOntologyBiologicalProcess	negative regulation of cilium-dependent cell motility	SEMG1 SEMG2	1.20e-04	4	93	2	GO:1902020
GeneOntologyBiologicalProcess	negative regulation of cilium movement	SEMG1 SEMG2	1.20e-04	4	93	2	GO:0003354
GeneOntologyBiologicalProcess	negative regulation of flagellated sperm motility	SEMG1 SEMG2	1.20e-04	4	93	2	GO:1901318
GeneOntologyBiologicalProcess	mating plug formation	SEMG1 SEMG2	1.20e-04	4	93	2	GO:0042628
Domain	-	ZNF182 ZNF845 ZNF142 ZEB1 SALL2 ZNF484 ZNF341 ZNF41 GLI2 ZFP41 ZNF180 GLIS2 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF488 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ATF2 ZNF548 ZEB2 ZFP82 ZFP37 ZNF587B ZNF710	6.67e-28	679	93	36	3.30.160.60
Domain	Znf_C2H2/integrase_DNA-bd	ZNF182 ZNF845 ZNF142 ZEB1 SALL2 ZNF484 ZNF341 ZNF41 GLI2 ZFP41 ZNF180 GLIS2 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF488 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ATF2 ZNF548 ZEB2 ZFP82 ZFP37 ZNF587B ZNF710	1.43e-27	694	93	36	IPR013087
Domain	ZINC_FINGER_C2H2_2	ZNF182 ZNF845 ZNF142 ZEB1 SALL2 ZNF484 ZNF341 ZNF41 GLI2 ZFP41 ZNF180 GLIS2 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF488 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ATF2 ZNF548 ZEB2 ZFP82 ZFP37 ZNF587B ZNF710	6.52e-26	775	93	36	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF182 ZNF845 ZNF142 ZEB1 SALL2 ZNF484 ZNF341 ZNF41 GLI2 ZFP41 ZNF180 GLIS2 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF488 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ATF2 ZNF548 ZEB2 ZFP82 ZFP37 ZNF587B ZNF710	7.13e-26	777	93	36	PS00028
Domain	Znf_C2H2-like	ZNF182 ZNF845 ZNF142 ZEB1 SALL2 ZNF484 ZNF341 ZNF41 GLI2 ZFP41 ZNF180 GLIS2 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF488 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ATF2 ZNF548 ZEB2 ZFP82 ZFP37 ZNF587B ZNF710	1.64e-25	796	93	36	IPR015880
Domain	Znf_C2H2	ZNF182 ZNF845 ZNF142 ZEB1 SALL2 ZNF484 ZNF341 ZNF41 GLI2 ZFP41 ZNF180 GLIS2 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF488 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ATF2 ZNF548 ZEB2 ZFP82 ZFP37 ZNF587B ZNF710	2.41e-25	805	93	36	IPR007087
Domain	ZnF_C2H2	ZNF182 ZNF845 ZNF142 ZEB1 SALL2 ZNF484 ZNF341 ZNF41 GLI2 ZFP41 ZNF180 GLIS2 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF488 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ATF2 ZNF548 ZEB2 ZFP82 ZFP37 ZNF587B ZNF710	2.74e-25	808	93	36	SM00355
Domain	zf-C2H2	ZNF182 ZNF845 ZNF142 SALL2 ZNF484 ZNF341 ZNF41 GLI2 ZFP41 ZNF180 GLIS2 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 ZFP14 ZNF721 ZBTB41 ZNF488 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ATF2 ZNF548 ZFP82 ZFP37 ZNF587B ZNF710	5.75e-24	693	93	33	PF00096
Domain	KRAB	ZNF182 ZNF845 ZNF484 ZNF41 ZNF180 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 ZFP14 ZNF860 ZNF772 ZNF229 ZNF496 ZNF548 ZFP82 ZFP37 ZNF587B	1.15e-14	358	93	19	PS50805
Domain	KRAB	ZNF182 ZNF845 ZNF484 ZNF41 ZNF180 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 ZFP14 ZNF860 ZNF772 ZNF229 ZNF496 ZNF548 ZFP82 ZFP37 ZNF587B	1.15e-14	358	93	19	PF01352
Domain	KRAB	ZNF182 ZNF845 ZNF484 ZNF41 ZNF180 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 ZFP14 ZNF860 ZNF772 ZNF229 ZNF496 ZNF548 ZFP82 ZFP37 ZNF587B	1.99e-14	369	93	19	SM00349
Domain	KRAB	ZNF182 ZNF845 ZNF484 ZNF41 ZNF180 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 ZFP14 ZNF860 ZNF772 ZNF229 ZNF496 ZNF548 ZFP82 ZFP37 ZNF587B	2.09e-14	370	93	19	IPR001909
Domain	zf-C2H2_6	ZNF182 ZNF845 SALL2 ZNF558 ZNF813 ZNF814 ZFP14 ZNF721 ZBTB41 ZNF860 ZNF229 RREB1 ZNF865 ZNF548 ZFP82 ZFP37 ZNF710	2.42e-13	314	93	17	PF13912
Domain	Semenogelin	SEMG1 SEMG2	2.45e-05	2	93	2	IPR008836
Domain	Semenogelin	SEMG1 SEMG2	2.45e-05	2	93	2	PF05474
Domain	CNH	NRK MINK1 MAP4K4	4.18e-05	14	93	3	SM00036
Domain	CNH	NRK MINK1 MAP4K4	5.21e-05	15	93	3	PF00780
Domain	CNH	NRK MINK1 MAP4K4	5.21e-05	15	93	3	PS50219
Domain	CNH_dom	NRK MINK1 MAP4K4	5.21e-05	15	93	3	IPR001180
Domain	Histatin/statherin	HTN1 HTN3	7.33e-05	3	93	2	IPR030773
Domain	C2H2_Znf_fam	ZNF641 PLAG1 ZNF496	2.24e-04	24	93	3	IPR027775
Domain	AWS	NSD2 ASH1L	2.43e-04	5	93	2	SM00570
Domain	AWS	NSD2 ASH1L	2.43e-04	5	93	2	PS51215
Domain	SAPAP	DLGAP2 DLGAP3	2.43e-04	5	93	2	IPR005026
Domain	GKAP	DLGAP2 DLGAP3	2.43e-04	5	93	2	PF03359
Domain	AWS_dom	NSD2 ASH1L	2.43e-04	5	93	2	IPR006560
Domain	S_TKc	NUAK1 NEK10 NEK8 NRK MINK1 IRAK4 MAP4K4 NUAK2	4.24e-04	359	93	8	SM00220
Domain	Di19_Zn_binding_dom	ZEB1 ZEB2	5.07e-04	7	93	2	IPR008598
Domain	zf-Di19	ZEB1 ZEB2	5.07e-04	7	93	2	PF05605
Domain	Pkinase	NUAK1 NEK10 NEK8 NRK MINK1 IRAK4 MAP4K4 NUAK2	6.27e-04	381	93	8	PF00069
Domain	PROTEIN_KINASE_ATP	NUAK1 NEK10 NEK8 NRK MINK1 IRAK4 MAP4K4 NUAK2	2.06e-03	459	93	8	PS00107
Domain	PROTEIN_KINASE_ST	NUAK1 NEK8 NRK MINK1 IRAK4 MAP4K4 NUAK2	2.21e-03	362	93	7	PS00108
Domain	Post-SET_dom	NSD2 ASH1L	2.81e-03	16	93	2	IPR003616
Domain	PostSET	NSD2 ASH1L	2.81e-03	16	93	2	SM00508
Domain	POST_SET	NSD2 ASH1L	2.81e-03	16	93	2	PS50868
Domain	Protein_kinase_ATP_BS	NUAK1 NEK10 NEK8 NRK MINK1 MAP4K4 NUAK2	2.85e-03	379	93	7	IPR017441
Domain	Prot_kinase_dom	NUAK1 NEK10 NEK8 NRK MINK1 IRAK4 MAP4K4 NUAK2	3.04e-03	489	93	8	IPR000719
Domain	PROTEIN_KINASE_DOM	NUAK1 NEK10 NEK8 NRK MINK1 IRAK4 MAP4K4 NUAK2	3.19e-03	493	93	8	PS50011
Domain	Kinase-like_dom	NUAK1 NEK10 NEK8 NRK MINK1 IRAK4 MAP4K4 NUAK2	5.62e-03	542	93	8	IPR011009
Domain	4_helix_cytokine-like_core	ZNF142 RREB1 ZNF496	6.00e-03	74	93	3	IPR009079
Domain	Ser/Thr_kinase_AS	NUAK1 NEK8 NRK MINK1 MAP4K4 NUAK2	8.86e-03	357	93	6	IPR008271
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	ZNF484 NUAK1 ZNF41 GLI2 ZNF180 ZNF641 ZNF558 ZNF552 ZFP14 ZNF721 ZNF860 ZNF772 HDAC10 ZNF496 ATF2 ZNF548 ZFP37 AXIN1 ZNF710	7.50e-06	1387	64	19	M734
Pathway	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	ZNF845 NUAK1 ZNF180 ZNF641 ZNF558 ZNF814 ZFP14 ZNF721 HDAC10 ZNF496 ZFP37 ZNF710	1.50e-04	768	64	12	MM14851
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	SART1 RSBN1 DLGAP3 ZNF845 ZNF142 ZEB1 GBF1 ZSCAN12 SLC4A7 GLI2 L1CAM CCNL1 ZNF813 ELOVL1 ZNF581 SLC39A10 NCLN ZFP82 ZFP37 SBSN ZNF587B AXIN1	1.39e-12	1203	96	22	29180619
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF182 ZNF845 ZNF41 ZNF558 ZNF813 ZNF552 ZNF721 ZNF229 ZFP82 ZNF587B	8.70e-11	181	96	10	37372979
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SART1 JARID2 ZEB1 ZSCAN12 ZFP41 ZNF180 GLIS2 ASH1L PLAG1 ZNF721 ZBTB41 ZNF496 ATF2 ZFP37 ZNF710	6.22e-09	808	96	15	20412781
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ZNF182 SLC4A7 ZNF341 FA2H CCNL1 ASH1L IRAK4 ZBTB41 PLD1 SLC39A10 ZNF496 ATF2 ZFP82 ZFP37 BRWD1	2.86e-07	1084	96	15	11544199
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SART1 SEMG1 RSBN1 SALL2 NSD2 CBY2 WDR20 ASH1L PLD1 RREB1 ZFP82 INO80B ALPL BRWD1	2.34e-06	1116	96	14	31753913
Pubmed	A new serine/threonine protein kinase, Omphk1, essential to ventral body wall formation.	NUAK1 NUAK2	7.54e-06	2	96	2	16715502
Pubmed	Rapid purification and characterization of histatins (histidine-rich polypeptides) from human whole saliva.	HTN1 HTN3	7.54e-06	2	96	2	2372245
Pubmed	ZEBs: Novel Players in Immune Cell Development and Function.	ZEB1 ZEB2	7.54e-06	2	96	2	30956067
Pubmed	Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis.	ZEB1 ZEB2	7.54e-06	2	96	2	28416756
Pubmed	Physical parameters of hydroxyapatite adsorption and effect on candidacidal activity of histatins.	HTN1 HTN3	7.54e-06	2	96	2	12711380
Pubmed	Zfhx1a and Zfhx1b mRNAs have non-overlapping expression domains during chick and mouse midgestation limb development.	ZEB1 ZEB2	7.54e-06	2	96	2	12609600
Pubmed	Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder.	ZEB1 ZEB2	7.54e-06	2	96	2	24306957
Pubmed	Smad-interacting protein 1 is a repressor of liver/bone/kidney alkaline phosphatase transcription in bone morphogenetic protein-induced osteogenic differentiation of C2C12 cells.	ZEB2 ALPL	7.54e-06	2	96	2	11477103
Pubmed	Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.	ZEB1 ZEB2	7.54e-06	2	96	2	20375168
Pubmed	Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma.	ZEB1 ZEB2	7.54e-06	2	96	2	29476046
Pubmed	Salivary Histatin 1 and 2 Are Targeted to Mitochondria and Endoplasmic Reticulum in Human Cells.	HTN1 HTN3	7.54e-06	2	96	2	32225006
Pubmed	[Isolation and structure determination of two peptides occurring in human seminal plasma].	SEMG1 SEMG2	7.54e-06	2	96	2	2757795
Pubmed	Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer.	ZEB1 ZEB2	7.54e-06	2	96	2	22213144
Pubmed	Histatins, a family of salivary histidine-rich proteins, are encoded by at least two loci (HIS1 and HIS2).	HTN1 HTN3	7.54e-06	2	96	2	2719677
Pubmed	Functional conservation of zinc-finger homeodomain gene zfh1/SIP1 in Drosophila heart development.	ZEB1 ZEB2	7.54e-06	2	96	2	16957952
Pubmed	Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay.	HTN1 HTN3	7.54e-06	2	96	2	18650243
Pubmed	Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II.	SEMG1 SEMG2	7.54e-06	2	96	2	8665951
Pubmed	SEMG1/2 augment energy metabolism of tumor cells.	SEMG1 SEMG2	7.54e-06	2	96	2	33311447
Pubmed	Ganglioside GM1 mediates decapacitation effects of SVS2 on murine spermatozoa.	SEMG1 SEMG2	7.54e-06	2	96	2	18753612
Pubmed	The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes.	TET3 ALPL	7.54e-06	2	96	2	21892189
Pubmed	Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry.	SEMG1 SEMG2	7.54e-06	2	96	2	8833737
Pubmed	Semen-coagulating protein, SVS2, in mouse seminal plasma controls sperm fertility.	SEMG1 SEMG2	7.54e-06	2	96	2	17123940
Pubmed	Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.	HTN1 HTN3	7.54e-06	2	96	2	3286634
Pubmed	The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2.	ZEB1 ZEB2	7.54e-06	2	96	2	37819755
Pubmed	Evolution of the hominoid semenogelin genes, the major proteins of ejaculated semen.	SEMG1 SEMG2	7.54e-06	2	96	2	14629036
Pubmed	Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues.	SEMG1 SEMG2	7.54e-06	2	96	2	12200457
Pubmed	Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.	ZEB1 ZEB2	7.54e-06	2	96	2	22892238
Pubmed	Functional implications of membrane modification with semenogelins for inhibition of sperm motility in humans.	SEMG1 SEMG2	7.54e-06	2	96	2	19089943
Pubmed	Structural relationship between human salivary histatins.	HTN1 HTN3	7.54e-06	2	96	2	2303595
Pubmed	Quantification of seminal plasma motility inhibitor/semenogelin in human seminal plasma.	SEMG1 SEMG2	7.54e-06	2	96	2	14581514
Pubmed	Gene structure of semenogelin I and II. The predominant proteins in human semen are encoded by two homologous genes on chromosome 20.	SEMG1 SEMG2	7.54e-06	2	96	2	1517240
Pubmed	The Zeb proteins δEF1 and Sip1 may have distinct functions in lens cells following cataract surgery.	ZEB1 ZEB2	7.54e-06	2	96	2	25082886
Pubmed	Knockdown of ubiquitin‑specific protease 51 attenuates cisplatin resistance in lung cancer through ubiquitination of zinc‑finger E‑box binding homeobox 1.	ZEB1 USP51	7.54e-06	2	96	2	32468048
Pubmed	Nucleotide sequence analysis of the human salivary protein genes HIS1 and HIS2, and evolution of the STATH/HIS gene family.	HTN1 HTN3	7.54e-06	2	96	2	8336540
Pubmed	Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.	ZEB1 ZEB2	7.54e-06	2	96	2	20025777
Pubmed	Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.	ZEB1 ZEB2	7.54e-06	2	96	2	20424117
Pubmed	Characterization of zinc finger protein 496 that interacts with Jumonji/Jarid2.	JARID2 ZNF496	7.54e-06	2	96	2	17521633
Pubmed	TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.	ZEB1 ZEB2	7.54e-06	2	96	2	21747944
Pubmed	Seminal vesicle secretion 2 acts as a protectant of sperm sterols and prevents ectopic sperm capacitation in mice.	SEMG1 SEMG2	7.54e-06	2	96	2	25395676
Pubmed	Localization of the genes for histatins to human chromosome 4q13 and tissue distribution of the mRNAs.	HTN1 HTN3	7.54e-06	2	96	2	2773933
Pubmed	The structure of the semenogelin gene locus--nucleotide sequence of the intergenic and the flanking DNA.	SEMG1 SEMG2	7.54e-06	2	96	2	8654389
Pubmed	Seminal vesicle protein SVS2 is required for sperm survival in the uterus.	SEMG1 SEMG2	7.54e-06	2	96	2	24591616
Pubmed	Human Semenogelin 1 Promotes Sperm Survival in the Mouse Female Reproductive Tract.	SEMG1 SEMG2	7.54e-06	2	96	2	32486486
Pubmed	The adaptive antioxidant response during fasting-induced muscle atrophy is oppositely regulated by ZEB1 and ZEB2.	ZEB1 ZEB2	7.54e-06	2	96	2	37948583
Pubmed	The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.	ZEB1 ZEB2	7.54e-06	2	96	2	28133913
Pubmed	Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection.	SEMG1 SEMG2	7.54e-06	2	96	2	22177559
Pubmed	Functional preservation of duplicated pair for RSVS III gene in the REST locus of rat 3q42.	SEMG1 SEMG2	7.54e-06	2	96	2	15582586
Pubmed	The cloning of a rapidly evolving seminal-vesicle-transcribed gene encoding the major clot-forming protein of mouse semen.	SEMG1 SEMG2	7.54e-06	2	96	2	8631362
Pubmed	Expression of semenogelins I and II and its prognostic significance in human prostate cancer.	SEMG1 SEMG2	7.54e-06	2	96	2	21557275
Pubmed	Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity.	ZEB1 ZEB2	7.54e-06	2	96	2	34550965
Pubmed	Rap2A links intestinal cell polarity to brush border formation.	MINK1 PLD1 MAP4K4	9.05e-06	15	96	3	22797597
Pubmed	A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors.	ZEB1 ZEB2	2.26e-05	3	96	2	21890822
Pubmed	TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression.	ZEB1 ZEB2	2.26e-05	3	96	2	31933004
Pubmed	Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.	ZEB1 ZEB2	2.26e-05	3	96	2	24968735
Pubmed	Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.	SLC4A7 NEK10	2.26e-05	3	96	2	19330027
Pubmed	Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran.	ZEB1 ZEB2	2.26e-05	3	96	2	31244281
Pubmed	miR-144-3p inhibited the growth, metastasis and epithelial-mesenchymal transition of colorectal adenocarcinoma by targeting ZEB1/2.	ZEB1 ZEB2	2.26e-05	3	96	2	34226299
Pubmed	Clustered organization of Krüppel zinc-finger genes at Xp11.23, flanking a translocation breakpoint at OATL1: a physical map with locus assignments for ZNF21, ZNF41, ZNF81, and ELK1.	ZNF182 ZNF41	2.26e-05	3	96	2	8088786
Pubmed	Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors.	SEMG1 SEMG2	2.26e-05	3	96	2	10411640
Pubmed	The potential role of regulator of G-protein signaling 16 in cell motility mediated by δEF1 family proteins.	ZEB1 ZEB2	2.26e-05	3	96	2	26823172
Pubmed	A miRNA signature associated with human metastatic medullary thyroid carcinoma.	ZEB1 ZEB2	2.26e-05	3	96	2	24127332
Pubmed	p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2.	ZEB1 ZEB2	2.26e-05	3	96	2	21518799
Pubmed	miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.	ZEB1 ZEB2	2.26e-05	3	96	2	25833697
Pubmed	Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor.	SEMG1 SEMG2	2.26e-05	3	96	2	11027412
Pubmed	House dust mite allergen Der f 2-induced phospholipase D1 activation is critical for the production of interleukin-13 through activating transcription factor-2 activation in human bronchial epithelial cells.	PLD1 ATF2	2.26e-05	3	96	2	19487697
Pubmed	miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.	ZEB1 ZEB2	2.26e-05	3	96	2	26022123
Pubmed	An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition.	ZEB1 ZEB2	2.26e-05	3	96	2	21411626
Pubmed	Langerhans cell maturation is accompanied by induction of N-cadherin and the transcriptional regulators of epithelial-mesenchymal transition ZEB1/2.	ZEB1 ZEB2	2.26e-05	3	96	2	24165969
Pubmed	Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.	ZEB1 ZEB2	2.26e-05	3	96	2	23412770
Pubmed	Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.	ZEB1 ZEB2	2.26e-05	3	96	2	29052277
Pubmed	GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.	ZEB1 GLI2	2.26e-05	3	96	2	23890107
Pubmed	Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase.	SEMG1 SEMG2	2.26e-05	3	96	2	9523691
Pubmed	Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta.	ZEB1 ZEB2	2.26e-05	3	96	2	17615296
Pubmed	miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.	ZEB1 ZEB2	2.26e-05	3	96	2	26556542
Pubmed	Localization of the transglutaminase cross-linking site in SVS III, a novel glycoprotein secreted from mouse seminal vesicle.	SEMG1 SEMG2	2.26e-05	3	96	2	11723121
Pubmed	Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen.	SEMG1 SEMG2	2.26e-05	3	96	2	15563730
Pubmed	Deletion of a Seminal Gene Cluster Reinforces a Crucial Role of SVS2 in Male Fertility.	SEMG1 SEMG2	2.26e-05	3	96	2	31540031
Pubmed	The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.	ZEB1 ZEB2	2.26e-05	3	96	2	18376396
Pubmed	The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.	ZEB1 ZEB2	2.26e-05	3	96	2	18411277
Pubmed	Major role of human KLK14 in seminal clot liquefaction.	SEMG1 SEMG2	2.26e-05	3	96	2	18482984
Pubmed	Association Between PD-L1 and Histatin1, 3 Expression in Advanced Head and Neck Squamous Cell Carcinoma.	HTN1 HTN3	2.26e-05	3	96	2	35489730
Pubmed	BMP4 signaling mediates Zeb family in developing mouse tooth.	ZEB1 ZEB2	2.26e-05	3	96	2	22350174
Pubmed	Regulation of ploidy and senescence by the AMPK-related kinase NUAK1.	NUAK1 NUAK2	2.26e-05	3	96	2	19927127
Pubmed	Syp-3, a third polymorphic locus for mouse seminal vesicle proteins.	SEMG1 SEMG2	2.26e-05	3	96	2	6626148
Pubmed	miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.	ZEB1 ZEB2	2.26e-05	3	96	2	29302045
Pubmed	A systematic survey of loss-of-function variants in human protein-coding genes.	HTN3 BPHL CBY2	3.02e-05	22	96	3	22344438
Pubmed	A census of human transcription factors: function, expression and evolution.	ZNF182 ZEB1 SALL2 NSD2 GLI2 ZNF180 ASH1L PLAG1 RREB1 ATF2 ZEB2	4.23e-05	908	96	11	19274049
Pubmed	Amidolytic activity of prostatic acid phosphatase on human semenogelins and semenogelin-derived synthetic substrates.	SEMG1 SEMG2	4.51e-05	4	96	2	11784334
Pubmed	Characterization of semenogelin II and its molecular interaction with prostate-specific antigen and protein C inhibitor.	SEMG1 SEMG2	4.51e-05	4	96	2	8665956
Pubmed	Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.	ZEB1 ZEB2	4.51e-05	4	96	2	25301070
Pubmed	miR-200b regulates cell migration via Zeb family during mouse palate development.	ZEB1 ZEB2	4.51e-05	4	96	2	22261924
Pubmed	Epididymal protease inhibitor (EPPIN) is a protein hub for seminal vesicle-secreted protein SVS2 binding in mouse spermatozoa.	SEMG1 SEMG2	4.51e-05	4	96	2	32044375
Pubmed	CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism.	ZEB1 USP51	4.51e-05	4	96	2	32296027
Pubmed	MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.	ZEB1 ZEB2	4.51e-05	4	96	2	17360662
Pubmed	Molecular mapping of statherin- and histatin-binding domains in human salivary mucin MG1 (MUC5B) by the yeast two-hybrid system.	HTN1 HTN3	4.51e-05	4	96	2	10728974
Interaction	RNF4 interactions	SART1 RSBN1 DLGAP3 ZNF845 ZNF142 ZEB1 GBF1 ZSCAN12 SLC4A7 GLI2 L1CAM CCNL1 ZNF813 ELOVL1 ZNF581 SLC39A10 NCLN ATF2 ZFP82 ZFP37 SBSN ZNF587B AXIN1	1.40e-07	1412	96	23	int:RNF4
Interaction	HTN1 interactions	HTN1 HTN3 GPR107	1.04e-06	5	96	3	int:HTN1
Interaction	ZNF467 interactions	RSBN1 ZNF845 DDX31 NSD2 PWP2 ZNF813 ZNF721 ZNF587B	2.26e-06	179	96	8	int:ZNF467
Interaction	ZNF692 interactions	ADCY10 DDX31 NSD2 PWP2	4.71e-05	42	96	4	int:ZNF692
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF845 ZNF180 ZNF813 ZNF814 ZNF552 ZFP14 ZNF772 ZNF581 ZNF229 ZNF865 ZNF548 ZFP82 SBSN ZNF587B	1.94e-07	1192	96	14	chr19q13
Cytoband	19q13.43	ZNF814 ZNF552 ZNF772 ZNF548	3.50e-05	87	96	4	19q13.43
Cytoband	19q13.42	ZNF845 ZNF813 ZNF581 ZNF865	1.43e-04	125	96	4	19q13.42
Cytoband	4q13	HTN1 HTN3	4.46e-04	15	96	2	4q13
Cytoband	6p25	BPHL RREB1	5.09e-04	16	96	2	6p25
Cytoband	2p13.1	TET3 INO80B	2.32e-03	34	96	2	2p13.1
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF182 ZNF845 ZNF142 ZEB1 ZSCAN12 SALL2 ZNF484 ZNF341 ZNF41 GLI2 ZFP41 ZNF180 GLIS2 ZNF641 ZNF558 ZNF813 ZNF814 ZNF552 PLAG1 ZFP14 ZNF721 ZBTB41 ZNF488 ZNF860 ZNF772 ZNF581 ZNF229 RREB1 ZNF496 ZNF865 ZNF548 ZEB2 ZFP82 ZFP37 ZNF587B ZNF710	2.38e-32	718	69	36	28
GeneFamily	Histatins and statherin	HTN1 HTN3	4.30e-05	3	69	2	971
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZEB1 ZEB2	1.46e-03	15	69	2	529
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4\|TCGA-Liver / Sample_Type by Project: Shred V9	SALL2 ZNF813 ZNF552 ZFP14 ZNF496 MAP4K4	1.80e-06	169	96	6	0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156
ToppCell	severe-CD8+_T_naive\|severe / disease stage, cell group and cell class	ZNF845 ZNF180 ZNF641 ZNF552 PLAG1 ZNF548	2.59e-06	180	96	6	94fe530367b170777f4051a4034cff06d80dbb83
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZNF182 NUAK1 NEK10 ZNF865 ZNF710	2.67e-05	162	96	5	ca30d9bf61f4133566fdc91c7996e130ea554d01
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma\|TCGA-Endometrium / Sample_Type by Project: Shred V9	DLGAP3 GLIS2 L1CAM PLAG1 NUAK2	2.83e-05	164	96	5	08c725548e751f815b4df778607270498204b353
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	DLGAP2 TMEM120A CDIN1 NEK8 ADGRA2	3.00e-05	166	96	5	65dafed953b01a9830b54309af75c7a561e88336
ToppCell	Nasal_Brush-Epithelial-Basal_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	USP51 MINK1 ZNF865 ZNF548 ZFP37	3.55e-05	172	96	5	58eaadf12366701103a0d1f133462c9495fedc30
ToppCell	Nasal_Brush-Epithelial-Basal_1\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	USP51 MINK1 ZNF865 ZNF548 ZFP37	3.55e-05	172	96	5	4483073469001770015526303772fd54906c5d68
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF182 SALL2 ZNF813 ZFP37 CCDC144NL	3.97e-05	176	96	5	ac83a6cd4bcbb9ca1fc02a9fbd9d9629ef1df8ca
ToppCell	severe-CD8+_T_naive\|World / disease stage, cell group and cell class	ZNF845 ZNF180 ZNF552 PLAG1 ZNF548	4.53e-05	181	96	5	69eeeb7f326e230b07495d557f708fbe3312ac0a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 GLI2 ADGRA2 ZEB2 PEAR1	5.03e-05	185	96	5	7092436b4db90289516ed130ade596e3021cffaf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 GLI2 ADGRA2 ZEB2 PEAR1	5.03e-05	185	96	5	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 GLI2 ADGRA2 ZEB2 PEAR1	5.03e-05	185	96	5	a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 GLI2 ADGRA2 ZEB2 PEAR1	5.03e-05	185	96	5	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	JARID2 NSD2 MAP4K4 SDK1 ZNF710	5.16e-05	186	96	5	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	JARID2 NSD2 MAP4K4 SDK1 ZNF710	5.16e-05	186	96	5	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 GLI2 ADGRA2 ZEB2 PEAR1	5.85e-05	191	96	5	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 GLI2 ADGRA2 ZEB2 PEAR1	5.85e-05	191	96	5	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	Hematolymphoid-Microglia-TYROBP----L1-3\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SLC4A7 MAP4K4 ZEB2 KNG1 ZNF710	7.27e-05	200	96	5	a20dce14f94777687aad57d6fbe3258ad376f63f
ToppCell	Hematolymphoid-Microglia-TYROBP--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SLC4A7 MAP4K4 ZEB2 KNG1 ZNF710	7.27e-05	200	96	5	dc344b3ec51d506952e38f0b3a7795d65f9dd4eb
ToppCell	Hematolymphoid-Microglia-TYROBP-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SLC4A7 MAP4K4 ZEB2 KNG1 ZNF710	7.27e-05	200	96	5	3bba5219453322198e8fdb0921d5f8c403598751
ToppCell	Hematolymphoid-Microglia\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SLC4A7 MAP4K4 ZEB2 KNG1 ZNF710	7.27e-05	200	96	5	21bcca3b670fe9bac034aef2275d3de4a9a73e2b
ToppCell	Hematolymphoid-Microglia-TYROBP---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SLC4A7 MAP4K4 ZEB2 KNG1 ZNF710	7.27e-05	200	96	5	a8646d0fca99f10827c2d2a12e584660ef7155f1
ToppCell	Hematolymphoid-Microglia-TYROBP\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SLC4A7 MAP4K4 ZEB2 KNG1 ZNF710	7.27e-05	200	96	5	33036d21c1c82109284473a515c4f890b33fdd5c
Computational	Neighborhood of PTK2	MARF1 ZFP14 MAP4K4 ZEB2 GPR107 ZNF710	5.30e-05	145	50	6	GCM_PTK2
Computational	Neighborhood of MAP4K4	MARF1 ZFP14 MAP4K4 ZEB2 GPR107 ZNF710	1.36e-04	172	50	6	GCM_MAP4K4
Computational	Neighborhood of PTPRD	MARF1 ZFP14 MAP4K4 ZEB2	1.46e-04	58	50	4	GCM_PTPRD
Computational	Neighborhood of CRKL	MARF1 ZFP14 MAP4K4 GPR107	2.14e-04	64	50	4	GCM_CRKL
Computational	Neighborhood of DLG1	MARF1 MAP4K4 GPR107 ZNF710	4.82e-04	79	50	4	GCM_DLG1
Drug	Disopyramide [3737-09-5]; Down 200; 11.8uM; PC3; HT_HG-U133A	ZSCAN12 MINK1 ASH1L INO80B AXIN1 GPR107 ZNF710 BRWD1	1.88e-06	197	96	8	7276_DN
Disease	urinary potassium to creatinine ratio	SLC4A7 NEK10	1.34e-04	6	89	2	EFO_0009882
Disease	Nephronophthisis	NEK8 GLIS2	3.19e-04	9	89	2	cv:C0687120
Disease	aortic valve stenosis (is_marker_for)	JARID2 BAMBI	4.86e-04	11	89	2	DOID:1712 (is_marker_for)
Disease	rheumatic heart disease (biomarker_via_orthology)	ZEB1 ZEB2	5.82e-04	12	89	2	DOID:0050827 (biomarker_via_orthology)
Disease	Nephronophthisis	NEK8 GLIS2	6.87e-04	13	89	2	C0687120
Disease	Spastic Paraplegia, Hereditary	FA2H L1CAM	8.00e-04	14	89	2	C0037773
Disease	Familial Nonmedullary Thyroid Cancer	ZEB1 WDR20 ZEB2	8.41e-04	61	89	3	C3501844
Disease	Nonmedullary Thyroid Carcinoma	ZEB1 WDR20 ZEB2	8.41e-04	61	89	3	C3501843
Disease	response to triptolide, cytotoxicity measurement	NEK10 ADGRA2	1.05e-03	16	89	2	EFO_0006952, EFO_0007662
Disease	lung non-small cell carcinoma (is_marker_for)	NSD2 L1CAM BAMBI AXIN1	1.74e-03	169	89	4	DOID:3908 (is_marker_for)
Disease	Papillary thyroid carcinoma	ZEB1 WDR20 ZEB2	2.27e-03	86	89	3	C0238463
Disease	Neoplasm Invasiveness	ZEB1 NUAK1 SLC39A10 ZEB2	2.37e-03	184	89	4	C0027626

Protein segments in the cluster

Peptide	Gene	Start	Entry
GWMVEHKHRHRHKHR	ASH1L	1476	Q9NR48
VHHGRRAHKSRAKGH	ADGRA2	1176	Q96PE1
VHFHGFMLDVHKRIH	AFG1L	161	Q8WV93
GGKACHKIFSNHHHR	ANKRD13C	46	Q8N6S4
HKIFSNHHHRLQLKA	ANKRD13C	51	Q8N6S4
FTNEDHLAVHKHKHE	ATF2	36	P15336
HHAHHAKHSKRSKSK	DLGAP2	266	Q9P1A6
HHHIFARGKRKGKNH	CCDC144NL	201	Q6NUI1
SLFLHIHVEKNRHFH	ADCY10	1171	Q96PN6
HNHGSPHLKAKHTRD	CCNL1	441	Q9UK58
HSDAAKKHRHERGHH	CCNL1	481	Q9UK58
PLKKELGHHHGEAHK	RAVER2	456	Q9HCJ3
VHHLALKDDVRHKVH	GPR107	41	Q5VW38
HHLSRYLKDVKQHHV	NCLN	481	Q969V3
LAHLHIHHVIHRDIK	MAP4K4	141	O95819
PLGEHFSSLKEKHHH	NEK10	611	Q6ZWH5
IGYRHWQKGKEHHHL	PEAR1	776	Q5VY43
AHLHLKHARSFHKTV	NDUFAF6	266	Q330K2
HFTARKGKRHHAHVN	NSD2	816	O96028
LHHVHTHLILHRDLK	NEK8	116	Q86SG6
HLVHRFNAHHGDTKV	MVD	286	P53602
KVHLGENKVHTARFH	LRATD1	246	Q96KN4
GSQRKHSKRHIHKDH	L1CAM	856	P32004
HHINNEHIHGEKKEF	GLI2	456	P10070
RKHIKAHGHFVSHEQ	GLIS2	311	Q9BZE0
HIFHVRSLHLGHVAK	DDX31	731	Q9H8H2
SLAGAHGHGVHKKKH	INO80B	26	Q9C086
IDHGHHEGKAKQALH	ALPL	336	P05186
SLKAHHVKHHFAHQK	FA2H	331	Q7L5A8
HVKHHFAHQKSGFGI	FA2H	336	Q7L5A8
ASFHHKLHHKRLAKE	CBY2	151	Q8NA61
AIAAAHAKQKHGLHR	HDAC10	151	Q969S8
LSRLHYSFHGHHSKK	BAMBI	191	Q13145
HIKRTHAKHHTSEAI	CDIN1	51	Q9Y2V0
GAKLDAAGLHHHRHV	AXIN1	521	O15169
HHHHQSRHGKRSKSK	DLGAP3	231	O95886
RKKDGQVTFLHVFHH	ELOVL1	131	Q9BW60
SEHKHRHTNIHKIDA	BRWD1	2026	Q9NSI6
SHAKRHHGYKRKFHE	HTN3	21	P15516
RKFHEKHHSHRGYRS	HTN3	31	P15516
KLHFQSCHGNVHKLH	MARF1	196	Q9Y4F3
DLRHRHGFHIILVHK	MARF1	461	Q9Y4F3
HIAAKTVFHLAHRHG	GBF1	1006	Q92538
QRKHNLGHGHKHERD	KNG1	436	P01042
FLHENHHIHRDIKSA	IRAK4	301	Q9NWZ3
HADFIHKHVKGSRLH	BPHL	251	Q86WA6
DFHGVHHGHITNLKK	SDK1	926	Q7Z5N4
LKVHFHRHREKYPHV	SALL2	416	Q9Y467
SDDKHMHDHNHRLRH	SLC39A10	166	Q9ULF5
VGKEADKLIHHGVHH	SBSN	126	Q6UWP8
SHEKRHHGYRRKFHE	HTN1	21	P15515
RKGKTHKHVHNGHVF	JARID2	211	Q92833
LAHLHAHKVIHRDIK	MINK1	141	Q8N4C8
AHLHAHRVIHRDIKG	NRK	166	Q7Z2Y5
AGPKHKGHKERHKHH	RSBN1	181	Q5VWQ0
HRGHKHHHRRRKDKE	SLC4A7	61	Q9Y6M7
LRVVHHKFHSQRHGS	TMEM120A	326	Q9BXJ8
RSHHNLIHGLKPHFK	PLD1	591	Q13393
HDKSKGHFHRVVIHH	SEMG1	116	P04279
GHFHRVVIHHKGGKA	SEMG1	121	P04279
HDKSKGHFHMIVIHH	SEMG2	116	Q02383
GVKRHHHKHNLKHRY	NUAK1	41	O60285
ERHHEKDHKRNHSMG	WDR20	471	Q8TBZ3
KRHHHKHNLRHRYEF	NUAK2	41	Q9H093
LTCHHRLHTGEKHYK	ZNF845	286	Q96IR2
FHRKDHLKNHLHTHD	PLAG1	101	Q6DJT9
KHIHKHAETKQHHLA	USP51	261	Q70EK9
EHYLKLHAHIHSGEK	ZNF341	606	Q9BYN7
VFHMRSHHKKEHAGP	ZNF488	291	Q96MN9
HQRTHAGKKAHGRGH	ZNF182	616	P17025
RFRESFHLSKHHVVH	ZNF865	586	P0CJ78
FKHKTDHIRHQRVHT	ZFP41	96	Q8N8Y5
IHQKARHAKHHGKDS	RREB1	1561	Q92766
CRSVLHHFHFKGSVH	PWP2	86	Q15269
LKSHKRIHTGENHHE	ZNF558	251	Q96NG5
TFIRHDHLTKHKKIH	ZBTB41	611	Q5SVQ8
AFIHSLHLNKHEKIH	ZNF721	441	Q8TF20
LEKMAIGHHIHDRAH	MLF1	151	P58340
IGHHIHDRAHVIKKS	MLF1	156	P58340
HHLKQHSLTHKGVKE	ZNF710	476	Q8N1W2
HLHHKRSLFLEQVHD	TET3	531	O43151
RHREHKKHKHRSGGS	SART1	31	O43290
VFNRKTHLAHHHRLH	ZNF813	531	Q6ZN06
GFCAKSALHKHQHIH	ZNF229	441	Q9UJW7
YKHHLKEHLRIHSGE	ZEB1	251	P37275
IPIRNHFHKHVSHAK	ZNF180	211	Q9UJW8
HVADHQGTHHKQKLH	ZNF587B	106	E7ETH6
CKKAFRQHSHLTHHL	ZFP82	511	Q8N141
KSHFIAHHRIHTGEK	ZNF41	661	P51814
HLARHRSHFHLKDKA	ZNF496	536	Q96IT1
VADHQGTHHKQKLHR	ZNF552	106	Q9H707
SFIKKSQLHEHHRIH	ZNF484	756	Q5JVG2
FIRKSHLVHHQKIHS	ZNF548	486	Q8NEK5
QRAHLIRHHKLHTGE	ZFP14	211	Q9HCL3
VFSRKSHHETHKRIH	ZNF860	546	A6NHJ4
CFKKRTHLVEHLHLH	ZNF142	171	P52746
GKAFKRASHLARHHS	ZNF581	121	Q9P0T4
FKHKHHLIEHSRLHS	ZEB2	1036	O60315
AFSQKAGLFHHIKIH	ZSCAN12	366	O43309
KAHGHKHALTDHLRI	ZFP37	356	Q9Y6Q3
KAFSHKHVLVQHHRI	ZNF772	441	Q68DY9
HVADHQGTHHKQKLH	ZNF814	106	B7Z6K7
HLIRHQKTHLHDKTS	ZNF641	306	Q96N77